Explore 1 seed startups based in Allschwil, Switzerland. Access verified founder contact information and fundraising data.
Get founder emails, funding data, and company details in one CSV
GlioCART is a University of Basel spin-out developing the first CAR-T cell therapy for glioblastoma (GBM), an aggressive brain cancer,
Get verified founder emails, funding details, and company data for 1 seed companies in Allschwil.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked